Active-ingredient Dossier
Codeine Phosphate Hemihydrate
Active-ingredient Dossier for Codeine Phosphate Hemihydrate (opioid analgesic). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: ASPEN
- Brand: LOGICIN
- Brand: PANAMAX
- Brand: PANADEINE
- Brand: Actacode
- Brand: AMCAL
- Therapeutic area: Pain Management
- Therapeutic area: Respiratory
What is
Codeine Phosphate Hemihydrate Codeine Phosphate Hemihydrate is an opioid analgesic.
Australian brands containing
Codeine Phosphate Hemihydrate — ASPEN — PANAMAX — PANADEINE — Actacode — AMCAL — APX-PARACETAMOL/CODEINE — ASPALGIN — CODALGIN — CODAPANE — COMFAROL — Dolased
Therapeutic areas
Codeine Phosphate Hemihydrate is registered in Pain Management (22 brands), Pain & Anaesthesia (8 brands), and Respiratory (2 brands).
Sponsor landscape
The ingredient is marketed by twelve sponsors: Sanofi-Aventis, Arrotex Pharmaceuticals, Aspen Pharmacare, Viatris, Cipla, and Sigma Company.
PBS and regulatory activity
Two brands containing Codeine Phosphate Hemihydrate have PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome was recorded on 1 July 2024, with two brands having PBAC outcomes on record and no AusPARs on record.